•
• 6 min read

Navigating Skyrizi: What You Need to Know About Pregnancy, Breastfeeding, and Beyond

Linwood Mark
Written by
Linwood Mark
Navigating Skyrizi: What You Need to Know About Pregnancy, Breastfeeding, and Beyond

Table of Contents

Understanding Skyrizi: An Overview of Its Benefits and Uses

A serene and inviting scene set in a bright, airy room filled with natural light filtering through large windows. The focal point is a comfortable, elegantly upholstered armchair draped with a soft, textured throw blanket in soothing earth tones. Nearby, a small wooden side table holds a steaming cup of herbal tea and a delicate stack of books with calming covers. In the background, a lush indoor plant adds a touch of green, symbolizing life and healing. The walls are adorned with gentle watercolor paintings of tranquil landscapes, enhancing the sense of peace. Soft, warm lighting casts a gentle glow, creating an atmosphere of comfort and relaxation, inviting viewers to imagine moments of self-care and reflection. The overall composition evokes a feeling of tranquility and wellness, making it an ideal visual representation of the supportive and healing aspects of managing health conditions like psoriasis and IBD with Skyrizi.

Skyrizi (risankizumab) is a humanized monoclonal antibody that targets interleukin-23 (IL-23), a cytokine involved in the inflammatory response that plays a significant role in immune-mediated diseases such as psoriasis and inflammatory bowel disease (IBD). By inhibiting IL-23, Skyrizi helps in reducing the inflammatory process in the body, leading to improvements in skin lesions, reduction of flares, and overall disease management. This therapy is particularly beneficial for individuals suffering from moderate to severe plaque psoriasis and is administered via subcutaneous injection.

The efficacy of Skyrizi has been demonstrated in various clinical trials, showcasing its ability to induce and maintain remission in patients who have previously failed other treatments. The drug is known for its favorable safety profile, with fewer serious adverse effects compared to traditional systemic therapies. This makes it an appealing choice for patients seeking effective and tolerable treatment options for their skin conditions and those with IBD.

The Impact of Skyrizi During Pregnancy: What Expecting Mothers Should Consider

A serene and inviting scene of a cozy, sunlit nursery filled with soft pastel colors, primarily shades of gentle greens and warm creams. In the foreground, a plush rocking chair is positioned beside a large window, allowing natural light to flood the room, casting delicate shadows on the wooden floor. The rocking chair is adorned with a fluffy, knitted throw blanket and a couple of plush toys, creating a sense of warmth and comfort. Against the wall, a beautifully arranged shelf displays an assortment of baby books, small potted plants, and decorative items that evoke a nurturing environment. A crib with a soft, cloud-patterned bedding set sits prominently in the center, surrounded by delicate mobile decorations hanging gently above it. In the background, a small changing table is neatly organized with pastel-colored baby essentials. The walls are painted in a soothing hue, perhaps a light mint green, accented with whimsical wall art featuring nature themes, such as gentle animals or blooming flowers. This peaceful ambiance highlights the connection between motherhood, care, and the importance of a safe space for both mother and child.

When it comes to pregnancy, the safety of medications is always a concern. For Skyrizi, the data regarding its use during pregnancy is still emerging. Current research indicates that there is limited information on the effects of Skyrizi on pregnancy outcomes. In animal studies, although no harmful effects on embryo-fetal development were found, the relevance of these findings to human pregnancy is uncertain.

pregnant women with autoimmune conditions, such as psoriasis or IBD, must carefully consider the risks and benefits of continuing Skyrizi during pregnancy. Discontinuation of the drug may lead to a flare-up of the underlying condition, which can also pose risks to both the mother and the fetus. Therefore, it is crucial for expecting mothers to engage in a thorough discussion with their healthcare providers to weigh the potential risks of Skyrizi against the risks associated with uncontrolled disease activity during pregnancy.

TablConsiderations for Skyrizi Use During Pregnancy

Factor Consideration
Clinical Evidence Limited data on human pregnancy outcomes.
Animal Studies No adverse effects on embryo-fetal development observed in animal studies.
Disease Management Risks of disease flare-ups if Skyrizi is discontinued.
Consultation Importance of discussing treatment plans with healthcare providers.

Breastfeeding While on Skyrizi: Safety Guidelines and Recommendations

breastfeeding mothers often face uncertainties regarding medication use, including biologics like Skyrizi. Current evidence suggests that Skyrizi is excreted in human breast milk; however, the effects on the nursing infant remain undetermined. The American Academy of Pediatrics considers Skyrizi to be compatible with breastfeeding, but mothers should monitor their infants for any potential adverse effects.

Healthcare providers typically recommend that breastfeeding mothers should continue with their treatment if the benefit to the mother outweighs any potential risks to the infant. Mothers who are taking Skyrizi should ensure they are adequately supported with resources and information to manage their breastfeeding journey effectively.

TablBreastfeeding Considerations for Skyrizi

Factor Consideration
Excretion in Milk Skyrizi is present in human breast milk.
Infant Monitoring Infants should be monitored for adverse effects if mothers are on Skyrizi.
Consultation Ongoing communication with healthcare providers is essential for safety.

Managing Skin Conditions with Skyrizi: Insights for New Mothers

New mothers managing skin conditions such as psoriasis or IBD while navigating the postpartum period may find it challenging to balance their health needs with motherhood. Skyrizi can provide significant relief from skin symptoms, improving the quality of life for those affected. However, the management of skin conditions during the postpartum period requires a comprehensive approach that considers both physical and emotional well-being.

Women may experience fluctuations in their condition during the postpartum period due to hormonal changes and stress. It is essential to establish a supportive care plan with healthcare providers, which may include regular check-ups and adjustments to treatment protocols as necessary.

Discussing Skyrizi with Your Healthcare Provider: Key Questions to Ask

When considering Skyrizi during pregnancy or while breastfeeding, it is vital to have open and informative discussions with your healthcare provider. Here are some key questions to ask:

  1. What are the potential risks of continuing Skyrizi during pregnancy?
  2. How will my underlying condition be managed if I stop taking Skyrizi?
  3. What is the current evidence regarding Skyrizi and breastfeeding?
  4. Are there any alternative treatments that are safer during pregnancy or while breastfeeding?
  5. How can I best monitor my health and my baby’s health while on Skyrizi?

These questions can help mothers make informed decisions regarding their treatment and ensure that they are supported throughout their journey.

FAQ

Can I take Skyrizi if I am planning to get pregnant? Discuss your plans with your healthcare provider, as they can help determine the best course of action and whether it is advisable to continue or adjust your treatment.

Is it safe to breastfeed while on Skyrizi? While Skyrizi is excreted in breast milk, it is generally considered compatible with breastfeeding. However, it is essential to monitor your baby for any adverse effects and consult with your healthcare provider.

What should I do if I experience a flare-up during pregnancy? Contact your healthcare provider immediately to discuss management options that are safe for both you and your baby.

Are there alternative treatments to Skyrizi during pregnancy? Yes, there may be alternative treatments available, but their safety and efficacy will depend on your specific condition. It’s crucial to consult with your doctor for personalized advice.

How can I ensure the health of my baby while on Skyrizi? Maintain regular check-ups with your healthcare provider and discuss any concerns you may have about your treatment and its effects on your baby.

References

  1. Current Biologic Therapies for Severe Asthma and Real-World Data: Are Expectations Being Met? Retrieved from https://doi.org/10.3390/jcm13237152
  2. Consensus Statements on Assessments and Vaccinations Prior to Commencement of Advanced Therapies for the Treatment of Inflammatory Bowel Diseases. Retrieved from https://pubmed.ncbi.nlm.nih.gov/11636097/
  3. Review Article: Green Management of IBD—New Paradigms for an Eco‐Friendly Approach
  4. Optimal Management of Patients with Moderate-to-Severe Inflammatory Bowel Disease. Retrieved from https://doi.org/10.3390/jcm13237026
  5. Electrostimulation: A Promising New Treatment for Psoriasis. Retrieved from https://doi.org/10.3390/ijms252313005
  6. Pregnancy. Retrieved from https://www.nhs.uk/pregnancy/
  7. Aesthetic Surgery in a Patient With Situs Inversus: A Rare Case Report About the Practical Concerns. Retrieved from https://pubmed.ncbi.nlm.nih.gov/11649279/
  8. Chylous Leak after Cystic Hygroma Excision in an Infant: A Rare Postoperative Complication. Retrieved from https://pubmed.ncbi.nlm.nih.gov/11649057/
  9. Pregnancy - week by week. Retrieved from https://www.betterhealth.vic.gov.au/health/healthyliving/pregnancy-week-by-week
  10. Am I Pregnant? Early Symptoms of Pregnancy & When To Test. Retrieved from https://my.clevelandclinic.org/health/articles/9709-pregnancy-am-i-pregnant
  11. Adolescents’ Sexual Reproductive Health Service Utilization and Associated Factors Among Bahir Dar City High School Students, Amhara Region, Ethiopia: A Cross-Sectional Study. Retrieved from https://pubmed.ncbi.nlm.nih.gov/11649351/
  12. The link between endocrine parameters, serum lithium concentrations, and cognitive functions among individuals with affective disorders at risk of suicidal behavior. A study protocol. Retrieved from https://doi.org/10.1371/journal.pone.0311347
  13. SMBE Secretary’s Report. Retrieved from https://pubmed.ncbi.nlm.nih.gov/11649377/
Linwood Mark
Written by
Linwood Mark

Linwood earned his Bachelor’s degree in Nutrition Science from Pennsylvania State University. He focuses on diet, fitness, and overall wellness in his health articles. In his free time, Linwood enjoys cooking, playing soccer, and volunteering at community health events.